Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-12-20

Clinical Trial Update: Anti-PD-1 and mDCF Followed by Chemoradiotherapy in Patients With Stage III Squamous Cell Anal Carcinoma. [Phase 2]

View source ↗

Summary

Phase II clinical trial evaluating Anti-PD-1 therapy followed by the mDCF chemotherapy regimen and chemoradiotherapy for stage III squamous cell carcinoma of th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 5-Fluorouracil (5-FU)
  • Anti-PD-1
  • CISPLATIN (cisplatin)
  • DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: Centre Hospitalier Universitaire de Besancon | Conditions: Squamous Cell Carcinoma of the Anus Stage III | Phase 2 | Status: ACTIVE_NOT_RECRUITING